Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Titel:
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
Auteur:
Bergman, Peter Blennow, Ola Hansson, Lotta Mielke, Stephan Nowak, Piotr Chen, Puran Söderdahl, Gunnar Österborg, Anders Smith, C. I. Edvard Wullimann, David Vesterbacka, Jan Lindgren, Gustaf Blixt, Lisa Friman, Gustav Wahren-Borgström, Emilie Nordlander, Anna Gomez, Angelica Cuapio Akber, Mira Valentini, Davide Norlin, Anna-Carin Thalme, Anders Bogdanovic, Gordana Muschiol, Sandra Nilsson, Peter Hober, Sophia Loré, Karin Chen, Margaret Sällberg Buggert, Marcus Ljunggren, Hans-Gustaf Ljungman, Per Aleman, Soo